Issue - meetings

Winter Maintenance Report

Meeting: 11/09/2006 - Executive Members for City Strategy and Advisory Panel (Item 38)

38 Winter Maintenance Service 2006/07 pdf icon PDF 36 KB

This report advises of the outcome of a review of last season’s Winter Maintenance Service and recommends the continued use of safecote as a treatment material, with no changes to the defined network for treatment of roads and footways.

Additional documents:

Minutes:

Members received a report which advised of the outcome of a review of last season’s Winter Maintenance Service and recommended the continued use of Safecote as a treatment material, with no changes to the defined network for treatment of roads and footways.

 

The report presented two options for consideration:

·  Option 1 – to formally approved the use of Safecote as the proprietary de-icing product for York’s road network;

·  Option 2 – to revert back to use of neat rock salt as the proprietary de-icing product for York’s road network.

 

Advice of the Advisory Panel

 

That the Executive Member for City Strategy be advised:

 

(i)         That the use of Safecote as the de-icing agent to be used during the winter maintenance season on the defined road network be approved;

 

(ii)        That the outcome of the analysis and risk assessment of the treatment of the Council’s car parks in wintry weather and the proposal not to carry out routine treatment but to carry out an annual risk assessment be noted;

 

(iii)       That each ward councillor be provided with a list of where the salt bins are and which ones are used, and that stickers be provided to indicate that the salt bins can be used.

 

Decision of the Executive Member for City Strategy

 

RESOLVED:That the advice of the Advisory Panel be accepted and endorsed.

 

REASON:(i) The trial of this material in 2005/06 has shown it to be a better de-icing agent than neat rock salt as well as bringing efficiency savings of £21,000;

 

                        (ii) The risks involved in not carrying out treatment balanced against the prohibitive costs of £350,000.


 

Feedback
Back to the top of the page